Honz Pharmaceutical Co., Ltd.

300086

CNE100000QM6

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
4.59 ^CNY	+0.44%		-4.77%	-21.81%

04-28	Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Hainan Yougeng Investment Co., Ltd. agreed to acquire Guangdong Yuanning Pharmaceutical Co.,Ltd. from Honz Pharmaceutical Co., Ltd. for CNY12 million.	CI

Honz Pharmaceutical Co., Ltd. Announces Implementation of 2020 Final Profit Distribution Plan, Payable on August 13, 2021

August 09, 2021 at 08:32 pm

Honz Pharmaceutical Co., Ltd. implemented 2020 final profit distribution plan with cash dividend (tax included) of CNY 0.20000000 per 10 shares. Record date is 12 August 2021, Ex-date is 13 August 2021 and Payment date is 13 August 2021.

Latest news about Honz Pharmaceutical Co., Ltd.

Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Hainan Yougeng Investment Co., Ltd. agreed to acquire Guangdong Yuanning Pharmaceutical Co.,Ltd. from Honz Pharmaceutical Co., Ltd. for CNY12 million.	26/10/23	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Honz Pharmaceutical Co., Ltd. cancelled the transaction announced on June 30, 2022	08/06/23	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/04/23	CI
Honz Pharma Optimistic Shortage of Fever Medicine Will be Solved	22/12/22	MT
Honz Pharmaceutical Co., Ltd. Announces Directorate Appointments	16/12/22	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22	CI
Honz Pharmaceutical Co., Ltd. announced that it expects to receive CNY 297.2405 million in funding	29/06/22	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	06/04/22	CI
Beijing Adds Fertility Treatment in Medical Insurance Program; Fertility Pharma Stocks Jump	22/02/22	MT
Honz Pharmaceutical Co., Ltd. cancelled the transaction announced on November 9, 2020	22/11/21	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21	CI
Honz Pharmaceutical Co., Ltd. Announces Implementation of 2020 Final Profit Distribution Plan, Payable on August 13, 2021	09/08/21	CI
Honz Pharmaceutical Co., Ltd. Approves 2020 Profit Distribution Plan At the Annual General Meeting Held on June 29, 2021	30/06/21	CI
Jinxin Fertility : to Buy 10% Stake in Controlling Shareholder of Two Hospitals for $6 Million	21/06/21	MT
Honz Pharmaceutical Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
Honz Pharmaceutical Co., Ltd. Announces Final Profit Distribution Proposal for 2020	26/04/21	CI
Honz Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	23/04/21	CI
Honz Pharmaceutical Co., Ltd. announced that it expects to receive CNY 634.6114 million in funding	08/11/20	CI

Chart Honz Pharmaceutical Co., Ltd.

Duration

Period

More charts

Company Profile

HONZ PHARMACEUTICAL CO., LTD., formerly HAINAN HONZ PHARMACEUTICAL CO., LTD., is principally engaged in the research, development, production and distribution of drugs for children. The Company provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The Company's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
HONZ PHARMACEUTICAL CO., LTD.	-21.81%	286M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.99%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.61B
ZYDUS LIFESCIENCES LIMITED	+60.18%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.35%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.63B